Wantstats
Company ProfilePremium

Elysium Health

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Elysium Health - Healthcare showcase

Year Founded & Workforce

2014

Industry

Healthcare

Services

Anti-Ageing
E

Elysium Health Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Elysium Health Overview

Company Headquarters: New York, US

Founded: 2014

Company Working:

Elysium Health is a life sciences company developing clinically-validated health products based on ageing research. The company is guided by a Scientific Advisory Board, which includes multiple winners of the Nobel Prize, as well as researchers and doctors who are experts in chemistry, physiology, neuroscience, complex chemical systems, biochemistry, and many other fields of study. The company has been best known for its cellular health supplement, BASIS. In September 2019, Elysium Health announced the acceptance of an Investigational New Drug ("IND") application by the Food and Drug Administration (FDA) to evaluate the efficacy of BASIS for the prevention of acute kidney injury (AKI) in surgical cardiac patients.

Strategy

Elysium Health works directly with top scientists, clinicians, and health professionals around the world to translate advances in science and technology into innovative health products. It aims to expand its geographical foothold in the global anti-ageing drugs market.

Company Snapshot

2014

Founded

New York, US

Headquarters

SWOT Analysis

Strengths

  • Strong focus on social media advertising
  • Partnerships with several research institutes, academic institutes, and clinicians

Weaknesses

  • Patent infringement lawsuits

Opportunities

  • Expansion in developing regions

Threats

  • Increasing market competition
  • Stringent political and regulatory environment

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
August 2018AgreementElysium Health entered into an exclusive license agreement with Mayo Clinic and Harvard University to use nicotinamide riboside for dietary supplement applications in the slowing of ageing and age-related diseases.
March 2017PartnershipMilner Therapeutics Institute, Elysium Health, and the academic scientists of the University of Cambridge partnered to discover and develop preventative medicines from natural products. The partnership is expected to reduce the risks and costs of development associated with the discovery process.

Product Offering

  • Elysium Health
    • Anti-Ageing

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →